Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

DECIPHERA PHARMACEUTICALS, INC.

(DCPH)
  Report
Delayed Nasdaq  -  04:00 2022-10-05 pm EDT
18.94 USD   -0.53%
09/27Stifel Adjusts Price Target on Deciphera Pharmaceuticals to $18 From $11, Reiterates Hold Rating
MT
09/12Piper Sandler Raises Deciphera Pharmaceuticals Price Target to $18 From $13, Maintains Neutral Rating
MT
09/12SVB Securities Adjusts Deciphera Pharmaceuticals' Price Target to $25 from $21, Maintains Outperform Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Event chart DECIPHERA PHARMACEUTICALS, INC.
Upcoming events on DECIPHERA PHARMACEUTICALS, INC.
11/09/22 Q3 2022 Earnings Release (Projected)
03/15/23 FY 2022 Earnings Release (Projected)
05/09/23 Q1 2023 Earnings Release (Projected)
08/03/23 Interim 2023 Earnings Release (Projected)
Past events on DECIPHERA PHARMACEUTICALS, INC.
09/12/22 | 06:00am European society for medical oncology congress - presentation no: 475p
09/11/22 | 07:30am European Society for Medical Oncology Congress
09/11/22 | 06:00am European society for medical oncology congress - presentation no: 1509p
09/10/22 | 05:05am European society for medical oncology congress - presentation no: 450o
08/04/22 | 08:00am Interim 2022 Earnings Call
08/04/22 | 07:00am Interim 2022 Earnings Release
06/23/22 | 08:30am Annual General Meeting
06/15/22 | 10:00am JMP Securities Life Sciences Conference - Fireside Chat
06/09/22 | 10:00am Jefferies Healthcare Conference - Fireside Chat
05/04/22 | 08:00am Q1 2022 Earnings Call
Past dividends on DECIPHERA PHARMACEUTICALS, INC.

- No events available -

Annual results
Fiscal Period : December201720182019202020212022
Sales
M $
Released
Forecast
Spread


 


 
25,0
24,1
3,8%
42,1
41,1
2,4%
96,1
95,3
0,89%
 
130
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-50,8
-45,6
-11%
-104

 
-200
-191
-4,5%
-269
-272
1,2%
-297
-304
2,3%
 
-172
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-50,9
-42,6
-20%
-104
-98,9
-5,3%
-201
-190
-5,7%
-271
-276
1,6%
-300
-299
-0,46%
 
-181
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-50,3
-39,7
-27%
-99,9
-95,9
-4,1%
-192
-182
-5,4%
-266
-269
0,77%
-300
-308
2,5%
 
-180
 
Net income
M $
Released
Forecast
Spread
-50,3
-39,8
-26%
-99,9
-95,4
-4,6%
-192
-183
-5,3%
-266
-270
1,2%
-300
-298
-0,52%
 
-178
 
EPS
$
Released
Forecast
Spread
-2,99
-2,51
-19%
-2,82
-2,67
-5,5%
-4,48
-4,15
-7,9%
-4,78
-4,84
1,3%
-5,16
-5,13
-0,54%
 
-2,53
 
Announcement Date03/28/201803/14/201903/09/202002/09/202102/08/2022-
Quarterly results
Fiscal Period : December2021 Q22021 Q32021 Q42022 Q12022 Q22022 Q3
Sales
M $
Released
Forecast
Spread
23,6
22,1
6,7%
23,2
23,6
-1,5%
24,2
23,3
3,9%
29,2
27,2
7,5%
32,5
30,1
7,9%
 
33,0
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-69,8
-65,0
-7,3%
-78,9
-76,0
-3,8%
-87,6
-95,0
7,8%
-46,1
-64,0
28%
-43,0
-46,0
6,6%
 
-42,0
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-70,5
-67,2
-4,9%
-79,7
-74,9
-6,4%
-88,4
-87,0
-1,6%
-46,9
-50,2
6,6%
-43,8
-46,1
5,1%
 
-44,2
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-70,4
-67,1
-5,0%
-79,8
-74,6
-7,1%
-88,4
-96,0
8,0%
-46,9
-52,8
11%
-43,1
-45,8
6,1%
 
-44,2
 
Net income
M $
Released
Forecast
Spread
-70,4
-66,7
-5,7%
-79,8
-74,9
-6,6%
-88,4
-86,8
-1,9%
-46,9
-50,2
6,6%
-43,1
-45,4
5,2%
 
-43,7
 
EPS
$
Released
Forecast
Spread
-1,21
-1,15
-5,2%
-1,37
-1,28
-6,7%
-1,51
-1,48
-2,0%
-0,80
-0,85
6,1%
-0,60
-0,66
8,5%
 
-0,58
 
Announcement Date08/03/202111/02/202102/08/202205/04/202208/04/2022-
Previous year Next Year
Upcoming sector events for DECIPHERA PHARMACEUTICALS, INC.
More events
Past sector events for DECIPHERA PHARMACEUTICALS, INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise